Clinical Trial Update: Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial [Phase 2]

View source ↗

Summary

The PREDICT trial is a Phase 2 targeted therapy study for metastatic prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Stage Ivb Prostate Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | Status: RECRUITING